Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joaquim Bellmunt, MD/PhD
Associacio Per la Recerca Oncológica (APRO)
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hopital Bordeaux University
Bordeaux, France
- Alexandra General Hospital of Athens
Athens, Greece
- Hospital Marqués de Valdecilla
Santander, Cantabria, Spain
- Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, Spain
- Hospital del Mar
Barcelona, Spain
- Clara Campal. Hospital Sanchinarro
Madrid, Spain
- Hospital Clínico San Carlos
Madrid, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario Virgen de la Victoria
Málaga, Spain
- Hospital General Universitario de Valencia
Valencia, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Feb 2013
- Primary completion
- 8 May 2017
- Completion
- 8 May 2017
- Last update posted
- 2 Oct 2017
- Registered enrollment
- 41
- Registry id
- NCT01784978
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.